Pamela Stephenson - Oct 24, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Commercial Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Oct 24, 2022
Transactions value $
-$2,036
Form type
4
Date filed
10/25/2022, 04:00 PM
Previous filing
Sep 27, 2022
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$2.04K -104 -0.23% $19.58 45.6K Oct 24, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 17,828 shares of common stock and 27,819 restricted stock units.